Reference:
1. Neves J, Sousa-Victor P. Regulation
of inflammation as an anti-aging intervention. 2020;287(1):43-52.
2. Moylan JS, Reid MB. Oxidative
stress, chronic disease, and muscle wasting. Muscle & nerve.
2007;35(4):411-29.
3. Jialal I, Devaraj S, Venugopal SK.
C-reactive protein: risk marker or mediator in atherothrombosis?
Hypertension (Dallas, Tex : 1979). 2004;44(1):6-11.
4. Ridker PM, Rifai N, Rose L, Buring
JE, Cook NR. Comparison of C-reactive protein and low-density
lipoprotein cholesterol levels in the prediction of first cardiovascular
events. The New England journal of medicine. 2002;347(20):1557-65.
5. Liuzzo G, Rizzello V. C-reactive
protein and primary prevention of ischemic heart disease. Clinica
chimica acta; international journal of clinical chemistry.
2001;311(1):45-8.
6. Ridker PM, Buring JE, Shih J,
Matias M, Hennekens CH. Prospective study of C-reactive protein and the
risk of future cardiovascular events among apparently healthy women.
Circulation. 1998;98(8):731-3.
7. Bektas A, Schurman SH, Sen R,
Ferrucci L. Aging, inflammation and the environment. Experimental
gerontology. 2018;105:10-8.
8. Joswig M, Hach-Wunderle V, Ziegler
R, Nawroth PP. Postmenopausal hormone replacement therapy and the
vascular wall: mechanisms of 17 beta-estradiol’s effects on vascular
biology. Experimental and clinical endocrinology & diabetes : official
journal, German Society of Endocrinology [and] German Diabetes
Association. 1999;107(8):477-87.
9. Barrett-Connor E, Stuenkel C.
Hormones and heart disease in women: Heart and Estrogen/Progestin
Replacement Study in perspective. The Journal of clinical endocrinology
and metabolism. 1999;84(6):1848-53.
10. Lobo RA. Hormone-replacement
therapy: current thinking. Nature reviews Endocrinology.
2017;13(4):220-31.
11. Krizova L, Dadakova K,
Kasparovska J, Kasparovsky T. Isoflavones. Molecules (Basel,
Switzerland). 2019;24(6).
12. Jiang Y, Gong P, Madak-Erdogan Z,
Martin T, Jeyakumar M, Carlson K, et al. Mechanisms enforcing the
estrogen receptor beta selectivity of botanical estrogens. FASEB journal
: official publication of the Federation of American Societies for
Experimental Biology. 2013;27(11):4406-18.
13. Weng L, Zhang F, Wang R, Ma W,
Song Y. A review on protective role of genistein against oxidative
stress in diabetes and related complications. Chemico-biological
interactions. 2019;310:108665.
14. Baumgartner-Parzer SM,
Waldenberger FR, Freudenthaler A, Ginouves-Guerdoux A, McGahie D, Gatto
H. The natural antioxidants, pomegranate extract and soy isoflavones,
favourably modulate canine endothelial cell function. ISRN veterinary
science. 2012;2012:590328.
15. Toro-Funes N, Morales-Gutierrez
FJ, Veciana-Nogues MT, Vidal-Carou MC, Spencer JP, Rodriguez-Mateos A.
The intracellular metabolism of isoflavones in endothelial cells. Food
& function. 2015;6(1):98-108.
16. Cepeda SB, Sandoval MJ,
Rauschemberger MB, Massheimer VL. Beneficial role of the phytoestrogen
genistein on vascular calcification. The Journal of nutritional
biochemistry. 2017;50:26-37.
17. Register TC, Cann JA, Kaplan JR,
Williams JK, Adams MR, Morgan TM, et al. Effects of soy isoflavones and
conjugated equine estrogens on inflammatory markers in atherosclerotic,
ovariectomized monkeys. The Journal of clinical endocrinology and
metabolism. 2005;90(3):1734-40.
18. Clarkson TB, Anthony MS, Morgan
TM. Inhibition of postmenopausal atherosclerosis progression: a
comparison of the effects of conjugated equine estrogens and soy
phytoestrogens. The Journal of clinical endocrinology and metabolism.
2001;86(1):41-7.
19. Verdrengh M, Jonsson IM, Holmdahl
R, Tarkowski A. Genistein as an anti-inflammatory agent. Inflammation
research : official journal of the European Histamine Research Society
[et al]. 2003;52(8):341-6.
20. Kim YK, Jang YY, Kim DH, Ko HH,
Han ES, Lee CS. Differential regulation of protein tyrosine kinase on
free radical production, granule enzyme release, and cytokine synthesis
by activated murine peritoneal macrophages. Biochemical pharmacology.
2001;61(1):87-96.
21. Erdman JW, Jr. AHA Science
Advisory: Soy protein and cardiovascular disease: A statement for
healthcare professionals from the Nutrition Committee of the AHA.
Circulation. 2000;102(20):2555-9.
22. Reynolds K, Chin A, Lees KA,
Nguyen A, Bujnowski D, He J. A meta-analysis of the effect of soy
protein supplementation on serum lipids. The American journal of
cardiology. 2006;98(5):633-40.
23. Huang Y, Cao S, Nagamani M,
Anderson KE, Grady JJ, Lu LJ. Decreased circulating levels of tumor
necrosis factor-alpha in postmenopausal women during consumption of
soy-containing isoflavones. The Journal of clinical endocrinology and
metabolism. 2005;90(7):3956-62.
24. Jenkins DJ, Kendall CW, Connelly
PW, Jackson CJ, Parker T, Faulkner D, et al. Effects of high- and
low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and
proinflammatory cytokines in middle-aged men and women. Metabolism:
clinical and experimental. 2002;51(7):919-24.
25. Acharjee S, Zhou JR, Elajami TK,
Welty FK. Effect of soy nuts and equol status on blood pressure, lipids
and inflammation in postmenopausal women stratified by metabolic
syndrome status. Metabolism. 2015;64(2):236-43.
26. Azadbakht L, Kimiagar M, Mehrabi
Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of
inflammation, and endothelial function - A cross-over study in
postmenopausal women with the metabolic syndrome. Diabetes Care.
2007;30(4):967-73.
27. Hall WL, Vafeiadou K, Hallund J,
Bügel S, Koebnick C, Reimann M, et al. Soy-isoflavone-enriched foods and
inflammatory biomarkers of cardiovascular disease risk in postmenopausal
women: Interactions with genotype and equol production. American Journal
of Clinical Nutrition. 2005;82(6):1260-8.
28. Lebon J, Riesco E, Tessier D,
Dionne IJ. Additive effects of isoflavones and exercise training on
inflammatory cytokines and body composition in overweight and obese
postmenopausal women: a randomized controlled trial. Menopause.
2014;21(8):869-75.
29. Liu ZM, Ho SC, Chen YM, Ho S, To
K, Tomlinson B, et al. Whole soy, but not purified daidzein, had a
favorable effect on improvement of cardiovascular risks: a 6-month
randomized, double-blind, and placebo-controlled trial in
equol-producing postmenopausal women. Molecular nutrition & food
research. 2014;58(4):709-17.
30. Aubertin-Leheudre M, Lord C,
Khalil A, Dionne IJ. Effect of 6 months of exercise and isoflavone
supplementation on clinical cardiovascular risk factors in obese
postmenopausal women: a randomized, double-blind study. Menopause.
2007;14(4):624-9.
31. Bakhtiari A, Hajian-Tilaki K,
Omidvar S, Nasiri-Amiri F. Clinical and metabolic response to soy
administration in older women with metabolic syndrome: a randomized
controlled trial. Diabetology & metabolic syndrome. 2019;11:47.
32. Christie DR, Grant J, Darnell BE,
Chapman VR, Gastaldelli A, Sites CK. Metabolic effects of soy
supplementation in postmenopausal Caucasian and African American women:
a randomized, placebo-controlled trial. Am J Obstet Gynecol.
2010;203(2):153.e1-9.
33. Colacurci N, Chiàntera A, Fornaro
F, De Novellis V, Manzella D, Arciello A, et al. Effects of soy
isoflavones on endothelial function in healthy postmenopausal women.
Menopause. 2005;12(3):299-307.
34. D’Anna R, Baviera G, Corrado F,
Cancellieri F, Crisafulli A, Squadrito F. The effect of the
phytoestrogen genistein and hormone replacement therapy on homocysteine
and C-reactive protein level in postmenopausal women. Acta Obstet
Gynecol Scand. 2005;84(5):474-7.
35. Greany KA, Nettleton JA, Wangen
KE, Thomas W, Kurzer MS. Consumption of isoflavone-rich soy protein does
not alter homocysteine or markers of inflammation in postmenopausal
women. Eur J Clin Nutr. 2008;62(12):1419-25.
36. Liu ZM, Ho SC, Chen YM, Ho YP.
The effects of isoflavones combined with soy protein on lipid profiles,
C-reactive protein and cardiovascular risk among postmenopausal Chinese
women. Nutrition, metabolism, and cardiovascular diseases : NMCD.
2012;22(9):712-9.
37. Dong JY, Wang P, He K, Qin LQ.
Effect of soy isoflavones on circulating C-reactive protein in
postmenopausal women: meta-analysis of randomized controlled trials.
Menopause (New York, NY). 2011;18(11):1256-62.
38. Moher D, Liberati A, Tetzlaff J,
Altman DG. Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement. PLoS medicine. 2009;6(7):e1000097.
39. Higgins J, Green S. Cochrane
Handbook for Systematic Reviews, version 5.0.2 The Cochrane
Collaboration: Joh Wiley & Sons Ltd; 2009.
40. Higgins JP, Thomas J. Cochrane
handbook for systematic reviews of interventions: wiley blackwell; 2020.
41. Hozo SP, Djulbegovic B, Hozo I.
Estimating the mean and variance from the median, range, and the size of
a sample. BMC medical research methodology. 2005;5(1):13.
42. DerSimonian R, Laird N.
Meta-analysis in clinical trials. Controlled clinical trials.
1986;7(3):177-88.
43. Higgins JP, Thompson SG.
Quantifying heterogeneity in a meta‐analysis. Statistics in medicine.
2002;21(11):1539-58.
44. Egger M, Smith GD, Schneider M,
Minder C. Bias in meta-analysis detected by a simple, graphical test.
Bmj. 1997;315(7109):629-34.
45. Begg CB, Berlin JA. Publication
bias and dissemination of clinical research. JNCI: Journal of the
National Cancer Institute. 1989;81(2):107-15.
46. Gonźalez S, Jayagopal V,
Kilpatrick ES, Chapman T, Atkin SL. Effects of isoflavone dietary
supplementation on cardiovascular risk factors in type 2 diabetes.
Diabetes Care. 2007;30(7):1871-3.
47. Llaneza P, González C,
Fernandez-Iñarrea J, Alonso A, Diaz F, Arnott I, et al. Soy isoflavones,
diet and physical exercise modify serum cytokines in healthy obese
postmenopausal women. Phytomedicine. 2011;18(4):245-50.
48. Llaneza P, Gonzalez C,
Fernandez-Inarrea J, Alonso A, Diaz F, Perez-Lopez FR. Soy isoflavones
improve insulin sensitivity without changing serum leptin among
postmenopausal women. Climacteric. 2012;15(6):611-20.
49. Mangano KM, Hutchins-Wiese HL,
Kenny AM, Walsh SJ, Abourizk RH, Bruno RS, et al. Soy proteins and
isoflavones reduce interleukin-6 but not serum lipids in older women: a
randomized controlled trial. Nutrition research (New York, NY).
2013;33(12):1026-33.
50. Nasca MM, Zhou JR, Welty FK.
Effect of soy nuts on adhesion molecules and markers of inflammation in
hypertensive and normotensive postmenopausal women. The American journal
of cardiology. 2008;102(1):84-6.
51. Riesco E, Choquette S, Audet M,
Lebon J, Tessier D, Dionne IJ. Effect of exercise training combined with
phytoestrogens on adipokines and C-reactive protein in postmenopausal
women: a randomized trial. Metabolism. 2012;61(2):273-80.
52. Ryan-Borchers TA, Park JS, Chew
BP, McGuire MK, Fournier LR, Beerman KA. Soy isoflavones modulate immune
function in healthy postmenopausal women. The American journal of
clinical nutrition. 2006;83(5):1118-25.
53. Törmälä R, Appt S, Clarkson TB,
Mueck AO, Seeger H, Mikkola TS, et al. Impact of soy supplementation on
sex steroids and vascular inflammation markers in postmenopausal women
using tibolone: Role of equol production capability. Climacteric.
2008;11(5):409-15.
54. van Nielen M, Feskens EJM,
Rietman A, Siebelink E, Mensink M. Partly replacing meat protein with
soy protein alters insulin resistance and blood lipids in postmenopausal
women with abdominal obesity. Journal of Nutrition. 2014;144(9):1423-9.
55. Yildiz MF, Kumru S, Godekmerdan
A, Kutlu S. Effects of raloxifene, hormone therapy, and soy isoflavone
on serum high-sensitive C-reactive protein in postmenopausal women.
International journal of gynaecology and obstetrics: the official organ
of the International Federation of Gynaecology and Obstetrics.
2005;90(2):128-33.
56. Haghighatdoost F, Hariri M. Can
resveratrol supplement change inflammatory mediators? A systematic
review and meta-analysis on randomized clinical trials. European journal
of clinical nutrition. 2019;73(3):345-55.
57. Haghighatdoost F, Hariri M. The
effect of alpha-lipoic acid on inflammatory mediators: a systematic
review and meta-analysis on randomized clinical trials. European journal
of pharmacology. 2019;849:115-23.
58. Tanaka K, Ohgo Y, Katayanagi Y,
Yasui K, Hiramoto S, Ikemoto H, et al. Anti-inflammatory effects of
green soybean extract irradiated with visible light. Sci Rep.
2014;4:4732.
59. Ganai AA, Khan AA, Malik ZA,
Farooqi H. Genistein modulates the expression of NF-kappaB and MAPK
(p-38 and ERK1/2), thereby attenuating d-Galactosamine induced fulminant
hepatic failure in Wistar rats. Toxicol Appl Pharmacol.
2015;283(2):139-46.
60. Agrawal A, Cha-Molstad H, Samols
D, Kushner I. Overexpressed nuclear factor-kappaB can participate in
endogenous C-reactive protein induction, and enhances the effects of
C/EBPbeta and signal transducer and activator of transcription-3.
Immunology. 2003;108(4):539-47.
61. Setchell KD, Clerici C. Equol:
history, chemistry, and formation. J Nutr. 2010;140(7):1355s-62s.
62. Franke AA, Lai JF, Halm BM,
Pagano I, Kono N, Mack WJ, et al. Equol production changes over time in
postmenopausal women. The Journal of nutritional biochemistry.
2012;23(6):573-9.
63. Hebuterne X. Gut changes
attributed to ageing: effects on intestinal microflora. Curr Opin Clin
Nutr Metab Care. 2003;6(1):49-54.